Eovaldi provides a veteran, durable anchor behind deGrom; his health and workload influence how aggressively Texas pursues depth and a true No. 3 or 4 starter.

Eovaldi pairs with deGrom to form a potent aces duo. His health history remains a critical variable, but when on the mound he offers elite consistency and the ability to anchor a deep rotation behind Texas' offense.

Eovaldi anchored Texas’ 2025 rotation with a standout 1.73 ERA and 129 strikeouts in 130 innings across 22 starts before a rotator cuff strain and sports hernia surgery curtailed his season. The six-to-eight week recovery window and expected normal offseason raise optimism for a return to ace form in 2026, though durability remains a concern as he approaches 35.

Eovaldi underwent bilateral sports hernia surgery, a key offseason note for Texas. At 35, he posted a 1.73 ERA over 130 innings this year before a rotator cuff strain ended his season; he signed a three-year, $75 million deal last winter, anchoring the Rangers’ rotation as they aim for continued success.

Runners-up in the value discussion, Eovaldi provided sturdy production for the Rangers with durable innings and competitive ratios, leveraging a favorable park and a reliable heater. He remains a steady option with a history of high-quality starts, though durability and age-related decline could temper the peak upside in 2026.